127 related articles for article (PubMed ID: 2539318)
1. A clinical appraisal of stage 1 mucinous carcinoma of the ovary.
Soeters R; Levin W; Tiltman A; Bloch B; Dehaeck CM
Gynecol Oncol; 1989 May; 33(2):222-4. PubMed ID: 2539318
[TBL] [Abstract][Full Text] [Related]
2. Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit.
Richardson MT; Mysona DP; Klein DA; Mann A; Liao CI; Diver EJ; Darcy KM; Tian C; She JX; Ghamande S; Van Le L; Kapp DS; Chan JK
Gynecol Oncol; 2020 Oct; 159(1):118-128. PubMed ID: 32828578
[TBL] [Abstract][Full Text] [Related]
3. Long-term prognosis of stage I ovarian carcinoma. Prognostic importance of intraoperative rupture.
Mizuno M; Kikkawa F; Shibata K; Kajiyama H; Suzuki T; Ino K; Kawai M; Mizutani S
Oncology; 2003; 65(1):29-36. PubMed ID: 12837980
[TBL] [Abstract][Full Text] [Related]
4. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
Rodríguez IM; Prat J
Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
[TBL] [Abstract][Full Text] [Related]
5. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
6. Survival impact of capsule status in stage I ovarian mucinous carcinoma-A mulicentric retrospective study.
Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():131-136. PubMed ID: 30685661
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary.
Massad LS; Gao F; Hagemann I; Powell M
Gynecol Obstet Invest; 2016; 81(5):411-5. PubMed ID: 26583769
[TBL] [Abstract][Full Text] [Related]
8. Mucinous carcinoma of the ovary. Clinicopathologic analysis.
Kikkawa F; Kawai M; Tamakoshi K; Suganuma N; Nakashima N; Furuhashi Y; Kuzuya K; Hattori S; Arii Y; Tomoda Y
Oncology; 1996; 53(4):303-7. PubMed ID: 8692534
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.
Gadducci A; Cosio S; Zola P; Sostegni B; Fuso L; Sartori E
Int J Gynecol Cancer; 2013 Mar; 23(3):461-8. PubMed ID: 23370604
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of radiotherapy for state I ovarian carcinoma].
Sheng X; Sun J; Zhou C
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):314-6. PubMed ID: 9387332
[TBL] [Abstract][Full Text] [Related]
11. Early-stage mucinous carcinoma (infiltrative type) of the ovary and fertility preservation.
Platero M; Espinosa I; Vega Suarez V; Gonzalez Martin A; Chiva L
Int J Gynecol Cancer; 2019 May; 29(4):835-839. PubMed ID: 30992327
[No Abstract] [Full Text] [Related]
12. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities.
Kaern J; Tropé CG; Abeler VM
Cancer; 1993 Mar; 71(5):1810-20. PubMed ID: 8383580
[TBL] [Abstract][Full Text] [Related]
13. Epithelial ovarian carcinoma of low malignant potential.
Barnhill D; Heller P; Brzozowski P; Advani H; Gallup D; Park R
Obstet Gynecol; 1985 Jan; 65(1):53-9. PubMed ID: 2981419
[TBL] [Abstract][Full Text] [Related]
14. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?
Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of borderline ovarian tumors clinical outcome and prognostic factors.
Lazarou A; Fotopoulou C; Coumbos A; Sehouli J; Vasiljeva J; Braicu I; Burger H; Kuehn W
Anticancer Res; 2014 Nov; 34(11):6725-30. PubMed ID: 25368281
[TBL] [Abstract][Full Text] [Related]
16. Impact of prognostic factors on survival rates in patients with ovarian carcinoma.
Arikan SK; Kasap B; Yetimalar H; Yildiz A; Sakarya DK; Tatar S
Asian Pac J Cancer Prev; 2014; 15(15):6087-94. PubMed ID: 25124578
[TBL] [Abstract][Full Text] [Related]
17. Mucinous carcinoma of the ovary. Pathologic prognostic factors.
Watkin W; Silva EG; Gershenson DM
Cancer; 1992 Jan; 69(1):208-12. PubMed ID: 1309304
[TBL] [Abstract][Full Text] [Related]
18. [Importance of clinically prognostic factors in the treatment of advanced ovarian carcinoma].
Albrecht M; Goepel E; Simon WE; Trams G
Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):482-7. PubMed ID: 2993094
[TBL] [Abstract][Full Text] [Related]
19. Treatment Outcomes of Epithelial Ovarian Cancers Following Maximum Cytoreduction and Adjuvant Paclitaxel-Carboplatin Chemotherapy: Egyptian NCI Experience.
Nassar HR; Zeeneldin AA; Helal AM; Ismail YM; Elsayed AM; Elbassuiony MA; Moneer MM
Asian Pac J Cancer Prev; 2015; 16(16):7237-42. PubMed ID: 26514517
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study.
Sabatier R; Calderon B; Lambaudie E; Chereau E; Provansal M; Cappiello MA; Viens P; Rousseau F
Int J Gynecol Cancer; 2015 Jun; 25(5):815-22. PubMed ID: 25768081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
